GlassScriptPhysician profile
Melissa Groves
NPI 1427320811
$1,822.39
in general payments reported to CMS, 2019-2025
24 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $529 · 2022: $272 · 2023: $160 · 2024: $548 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $476.69 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $411.56 | 2021-2024 | Farxiga, Airsupra |
| Eisai INC. | $125.00 | 2024 | |
| Lilly USA, LLC | $120.02 | 2021-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $102.10 | 2021-2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.94 | 2021-2025 | Jardiance |
| Astellas Pharma US INC | $68.83 | 2025 | Veozah |
| Amgen INC. | $53.87 | 2021-2024 | Repatha, Otezla |
| Pfizer INC. | $46.27 | 2021 | |
| Janssen Pharmaceuticals, INC | $43.23 | 2021 | |
| Axsome Therapeutics, INC. | $34.39 | 2025 | Symbravo |
| Exact Sciences Corporation | $33.41 | 2023 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $31.44 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $29.50 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $26.77 | 2022-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $18.39 | 2025 | Extended Holter |
| Novartis Pharmaceuticals Corporation | $18.29 | 2024 | |
| Alexion Pharmaceuticals, INC. | $17.82 | 2021 | |
| Lundbeck LLC | $16.72 | 2021 | |
| Grifols USA, LLC | $16.59 | 2024 | Prolastin-C Liquid |
| Amarin Pharma, INC. | $15.60 | 2021 | |
| Evoke Pharma, INC. | $14.28 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.44 | 2022 | |
| Shield Therapeutics INC | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Groves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.